Sam Backenroth
2021 - Ohr Pharmaceutical
In 2021, Sam Backenroth earned a total compensation of $1.2M as Former Chief Financial Officer at Ohr Pharmaceutical, a 225% increase compared to previous year.
Compensation breakdown
Bonus | $140,000 |
---|---|
Option Awards | $639,023 |
Salary | $363,462 |
Other | $23,330 |
Total | $1,165,814 |
Backenroth received $639K in option awards, accounting for 55% of the total pay in 2021.
Backenroth also received $140K in bonus, $363.5K in salary and $23.3K in other compensation.
Rankings
In 2021, Sam Backenroth's compensation ranked 8,230th out of 12,415 executives tracked by ExecPay. In other words, Backenroth earned more than 33.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,230 | 34th |
Manufacturing | 3,643 | 34th |
Chemicals And Allied Products | 1,621 | 32nd |
Drugs | 1,441 | 31st |
Pharmaceutical Preparations | 1,072 | 31st |
Backenroth's colleagues
We found two more compensation records of executives who worked with Sam Backenroth at Ohr Pharmaceutical in 2021.